Results 1 to 10 of about 45,090 (245)
Pheochromocytoma is a rare disease that is characterized by the increased production and secretion of catecholamines from the adrenal medulla. The disease is autosomal dominant, and frequently sporadic and unilateral. Pheochromocytoma, which is diagnosed
Sezer Acar +9 more
doaj +2 more sources
Metoclopramide‐Induced Pheochromocytoma Crisis: A Case Report and Literature Review [PDF]
Pheochromocytoma is a catecholamine‐secreting neuroendocrine tumor originating in the adrenal medulla. In patients with pheochromocytoma, paroxysmal over‐secretion of catecholamines can be triggered by various medications, including the commonly used ...
Yuki Yamanishi +4 more
doaj +2 more sources
Composite pheochromocytoma associated with neurofibromatosis type 1
Introduction Composite pheochromocytoma is a rare tumor, occurring in only 3% of pheochromocytomas. We report a case of composite pheochromocytoma with neurofibromatosis type 1.
Akira Tachibana +5 more
doaj +2 more sources
From Childhood Migraine Headache to Pheochromocytoma [PDF]
Pheochromocytoma may have multiple clinical manifestations including paroxysmal hypertension, tachycardia, sweating, nausea, and headache (Phillips et al., 2002). Migraine has some of the manifestations seen with pheochromocytoma.
Y. M. Hazimeh +3 more
doaj +2 more sources
BackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare syndrome that presents as medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
Yaohan Li +5 more
doaj +1 more source
Introduction Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism.
Koshiro Nishimoto +11 more
doaj +1 more source
Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. [PDF]
Metastatic pheochromocytoma represents one of the major clinical challenges in the field of neuroendocrine oncology. Recent molecular characterization of pheochromocytoma suggests new treatment options with targeted therapies.
Alessio Giubellino +9 more
doaj +1 more source
ObjectivePheochromocytoma is a rare catecholamine-producing neuroendocrine tumour originating from the chromaffin cells of the adrenal medulla or extra-adrenal paraganglia. However, there are few bibliometric studies on Pheochromocytoma.
Bi-ling Huang +17 more
doaj +1 more source
Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy [PDF]
Importance Large studies investigating long-term outcomes of patients with bilateral pheochromocytomas treated with either total or cortical-sparing adrenalectomies are needed to inform clinical management.Objective To determine the association of ...
Eng, Charis +2 more
core +2 more sources
Pheochromocytoma with Takotsubo Syndrome and acute heart failure: a case report
Background Pheochromocytoma is a neuroendocrine tumor that can overproduce catecholamines. Heart failure and Takotsubo Syndrome (TTS) caused by excessive catecholamines are uncommon pheochromocytoma complications.
Lin Yang +3 more
doaj +1 more source

